PEA, FEDERICO
PEA, FEDERICO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
[Mutant Prevention Concentration: is it significant in the clinical practice?]
2008 Pea, Federico
[PK/PD profile and post-marketing surveillance of levofloxacin]
2009 Pea, Federico
A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: One stone for two birds?
2016 Pea F.; Cojutti P.; Dose L.; Baraldo M.
A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
2017 Pea F.; Cojutti P.G.; Baraldo M.
A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy
2015 Cojutti P.; Scarparo C.; Sartor A.; Coato P.; Rigoli R.; Pea F.
A Comparative Analysis of the Urinary Excretion Profiles of Mesna and Argimesna Following Oral Administration to Healthy Volunteers
1992 Miglioli P.A.; Pea F.; Mazzo M.; Berti T.; Casiglia E.; Pessina A.; Moretti V.; De Pascale A.; Palatini P.
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol
2021 Gatti, Milo; Bartoletti, Michele; Cojutti, Pier Giorgio; Gaibani, Paolo; Conti, Matteo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections
2023 Gatti, Milo; Viale, Pierluigi; Cojutti, Pier Giorgio; Zamparini, Eleonora; De Paolis, Massimiliano; Giannella, Maddalena; Pea, Federico; Tedeschi, Sara
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF)
2023 Gatti M.; Rinaldi M.; Gaibani P.; Siniscalchi A.; Tonetti T.; Giannella M.; Viale P.; Pea F.
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia
2023 Gatti, Milo; Pascale, Renato; Cojutti, Pier Giorgio; Rinaldi, Matteo; Ambretti, Simone; Conti, Matteo; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia
2023 Gatti, Milo; Rinaldi, Matteo; Gaibani, Paolo; Siniscalchi, Antonio; Tonetti, Tommaso; Viale, Pierluigi; Pea, Federico
A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients
2020 Barco S.; Mesini A.; Barbagallo L.; Maffia A.; Tripodi G.; Pea F.; Saffioti C.; Castagnola E.; Cangemi G.
A multi-society position paper on the prevention and management of nosocomial and severe infections: the Italian Society for Infectious Diseases, the Italian Multidisciplinary Society of Hospital Infections, the Italian Society of Chemotherapy, the Italian Society of Respiratory Medicine, the Italian Society of Clinical Microbiology, the Italian Society of Microbiology, and GISIG
2010 Ippolito G.; Carosi G.; Moroni M.; Nicastri E.; Lauria F.N.; Mazzotta F.; Goglio A.; Pea F.; Blasi F.; Fortina G.; Rossano F.
A multicenter, real-world experience with recombinant FXIII for the treatment of patients with FXIII deficiency: from pharmacokinetics to clinical practice. The Italian FXIII Study
2022 Zanon, Ezio; Pasca, Samantha; Sottilotta, Gianluca; Molinari, Angelo C; Ferretti, Antonietta; Di Gregorio, Patrizia; Pollio, Berardino; Pizzuti, Michele; Notarangelo, Lucia Dora; Biasoli, Chiara; Cojutti, Piergiorgio; Pea, Federico; Simioni, Paolo; Peyvandi, Flora
A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care
2019 Vanino E.; Tadolini M.; Attard L.; Cascavilla A.; Pea F.; Viale P.
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections
2023 Gatti, Milo; Tam, Vincent H; Gaibani, Paolo; Cojutti, Pier Giorgio; Viale, Pierluigi; Pea, Federico
A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric Settings
2021 Gatti M.; Cojutti P.G.; Campoli C.; Caramelli F.; Corvaglia L.T.; Lanari M.; Pession A.; Ramirez S.; Viale P.; Pea F.
A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis
2022 Gatti, M; Tedeschi, S; Trapani, F; Ramirez, S; Mancini, R; Giannella, M; Viale, P; Pea, F
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
2021 Bassetti M.; Giacobbe D.R.; Bruzzi P.; Barisione E.; Centanni S.; Castaldo N.; Corcione S.; De Rosa F.G.; Di Marco F.; Gori A.; Gramegna A.; Granata G.; Gratarola A.; Maraolo A.E.; Mikulska M.; Lombardi A.; Pea F.; Petrosillo N.; Radovanovic D.; Santus P.; Signori A.; Sozio E.; Tagliabue E.; Tascini C.; Vancheri C.; Vena A.; Viale P.; Blasi F.
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment?
2018 Posteraro B.; Pea F.; Masucci L.; Posteraro P.; Sanguinetti M.